BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 983613)

  • 1. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between type I and type II substrate binding to cytochrome P-450 by variation of temperature.
    Misselwitz R; Jänig GR; Rein H; Buder E; Zirwer D; Ruckpaul K
    Acta Biol Med Ger; 1976; 35(5):K 19-25. PubMed ID: 983603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NADPH-dependent cytochrome P-450 reduction in liver microsomes of rats of different ages with and without phenobarbital pretreatment.
    Müller D; Lübbe H; Klinger W
    Acta Biol Med Ger; 1975; 34(8):1333-7. PubMed ID: 1210995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary lipid on drug-metabolizing enzymes.
    Wade AE; Norred WP
    Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hexobarbital-oxidation in vivo and in vitro in rats after phenobarbital-pretreatment or after portacaval anastomosis (author's transl)].
    Richter E; Gallenkamp H; Brachtel D; Grün M
    Z Gastroenterol; 1977 Jun; 15(6):389-92. PubMed ID: 888489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interactions of inducers, inhibitors, and substrates of drug-metabolizing enzymes with rat liver cytochrome P-450.
    Soliman MR; Johnson HD; Wade AE
    Drug Metab Dispos; 1974; 2(1):87-96. PubMed ID: 4150140
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of drug metabolizing enzymes by diazepam in rat liver.
    Vorne M; Idänpään-Heikkilä J
    Experientia; 1975 Aug; 31(8):962-3. PubMed ID: 1157872
    [No Abstract]   [Full Text] [Related]  

  • 9. Luminol-and lucigenin-amplified chemiluminescence with rat liver microsomes. Kinetics and influence of ascorbic acid, glutathione, dimethylsulfoxide, N-t-butyl-a-phenyl-nitrone, copper-ions and a copper complex, catalase, superoxide dismutase, hexobarbital and aniline.
    Klinger W; Karge E; Kretzschmar M; Rost M; Schulze HP; Dargel R; Reinemann C; Rein H
    Exp Toxicol Pathol; 1996 Jul; 48(5):447-60. PubMed ID: 8765690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyproterone acetate pretreatment on the in vitro metabolism of aniline, hexobarbital and 3 H-digitoxigenin.
    Talcott RE; Stohs SJ
    J Pharmacol Exp Ther; 1973 Feb; 184(2):419-23. PubMed ID: 4688178
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of phenobarbital on the impairment of drug metabolism by carrageenan-induced inflammation in male rat.
    Sasaki K; Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):377-80. PubMed ID: 2236905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene.
    Cresteil T; Beaune P; Celier C; Leroux JP; Guengerich FP
    J Pharmacol Exp Ther; 1986 Jan; 236(1):269-76. PubMed ID: 3941398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary protein quality on drug metabolism in the rat.
    Miranda CL; Webb RE
    J Nutr; 1973 Oct; 103(10):1425-30. PubMed ID: 4745519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of inhibition of rat liver microsomal monooxygenases during the development of cholestasis].
    Zakharova NE; Pospelova LN; Gromova OA; Tsyrlov IB; Liakhovich VV
    Vopr Med Khim; 1977; 23(2):181-5. PubMed ID: 883154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the significance of drug-induced spectral changes in liver microsomes.
    Orrenius S; Wilson BJ; von Bahr C; Schenkman JB
    Biochem Soc Symp; 1972; 34():55-77. PubMed ID: 4144196
    [No Abstract]   [Full Text] [Related]  

  • 17. The incomplete conversion of hepatic cytochrome P-450 to P-420 by mercurials.
    Franklin MR
    Mol Pharmacol; 1972 Nov; 8(6):711-21. PubMed ID: 4344998
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of phospholipids on the differential spectra of the binding of microsomal cytochrome P-450 with substrates].
    Diatlovitskaia EV; Petkova DKh; Lemenovskaia AF; Bergel'son LD
    Biokhimiia; 1984 Apr; 49(4):551-5. PubMed ID: 6733159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of microsomal hydroxylase: involvement of a second factor besides cytochrome P-450.
    Remmer H
    Hoppe Seylers Z Physiol Chem; 1968 Nov; 349(11):1621-4. PubMed ID: 5745914
    [No Abstract]   [Full Text] [Related]  

  • 20. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.